Literature DB >> 20606064

Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole.

Anne Marie Queenan1, Wenchi Shang, Karen Bush, Robert K Flamm.   

Abstract

Single-step Pseudomonas aeruginosa mutants, selected with ceftobiprole, ceftazidime, or cefepime, were generated at frequencies of 10(-6) to <10(-9) at two and four times the MIC. The chromosomal AmpC β-lactamase activity was increased in all ceftazidime-selected mutants. Mutants selected with cefepime either increased AmpC activity or upregulated expression of the mexXY efflux genes. Mutants selected with ceftobiprole did not overexpress AmpC; 90% of these produced elevated levels of mexXY RNA, indicating that increased efflux, not AmpC derepression, is the predominant response to ceftobiprole during first-step mutations in P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606064      PMCID: PMC2944577          DOI: 10.1128/AAC.00060-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Authors:  John Quale; Simona Bratu; Jyoti Gupta; David Landman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.

Authors:  S Westbrock-Wadman; D R Sherman; M J Hickey; S N Coulter; Y Q Zhu; P Warrener; L Y Nguyen; R M Shawar; K R Folger; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

3.  Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Patrice Nordmann; Farid El Garch; Ludovic Cabanne; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy.

Authors:  M Matthew; A M Harris
Journal:  J Gen Microbiol       Date:  1976-05

5.  Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR.

Authors:  Jean-Luc Dumas; Christian van Delden; Karl Perron; Thilo Köhler
Journal:  FEMS Microbiol Lett       Date:  2006-01       Impact factor: 2.742

6.  Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation.

Authors:  B Henrichfreise; I Wiegand; W Pfister; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Authors:  Daniel J Wolter; Ellen Smith-Moland; Richard V Goering; Nancy D Hanson; Philip D Lister
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

8.  A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.

Authors:  Narcisa Mesaros; Youri Glupczynski; Laëtitia Avrain; Nancy E Caceres; Paul M Tulkens; Françoise Van Bambeke
Journal:  J Antimicrob Chemother       Date:  2007-02-08       Impact factor: 5.790

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles.

Authors:  Somvadee Laohavaleeson; Karen Lolans; John P Quinn; Joseph L Kuti; David P Nicolau
Journal:  Infect Drug Resist       Date:  2008-11-23       Impact factor: 4.003

View more
  10 in total

Review 1.  Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.

Authors:  Yahiya Y Syed
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

2.  Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.

Authors:  Mariana Castanheira; Janet C Mills; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

3.  Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens.

Authors:  Samuel A Shelburne; Jiwoong Kim; Jose M Munita; Pranoti Sahasrabhojane; Ryan K Shields; Ellen G Press; Xiqi Li; Cesar A Arias; Brandi Cantarel; Ying Jiang; Min S Kim; Samuel L Aitken; David E Greenberg
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

4.  Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.

Authors:  Rajbharan Yadav; Jürgen B Bulitta; Elena K Schneider; Beom Soo Shin; Tony Velkov; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

5.  MexXY multidrug efflux system of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

6.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

7.  Biofilm Formation and β-Lactamase Production in Burn Isolates of Pseudomonas aeruginosa.

Authors:  Samira Heydari; Fereshteh Eftekhar
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

Review 8.  Mechanisms of action and antimicrobial activity of ceftobiprole.

Authors:  M I Morosini; M Díez-Aguilar; R Cantón
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

9.  Mortality in patients with carbapenem-resistant Pseudomonas aeruginosa with and without susceptibility to traditional antipseudomonal β-lactams.

Authors:  Jessica Howard-Anderson; Chris W Bower; Gillian Smith; Sarah W Satola; Jesse T Jacob
Journal:  JAC Antimicrob Resist       Date:  2021-12-17

10.  Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.

Authors:  Benjamin K Chan; Mark Sistrom; John E Wertz; Kaitlyn E Kortright; Deepak Narayan; Paul E Turner
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.